The In Vitro and In Vivo Effects of Anti-Galactose Antibodies on Endothelial Cell Activation and Xenograft Rejection 1

We have previously produced a series of antigalactose (anti-Gal) hybridomas and characterized their heavy chain gene usage. Here we have quantified the affinity of these Abs for the α-Gal epitope and characterized their in vitro effects on endothelial cell activation and apoptosis. We report that anti-Gal mAbs derived from Gal−/− mice show a range of affinity for the α-Gal epitope, and that affinity was generally increased as the VH gene usage transitioned from germline sequences to sequences exhibiting somatic maturation. Despite an 85-fold range in affinity, all the anti-Gal mAbs examined induced α-Gal-specific endothelial cell activation, and after prolonged exposure induced endothelial cell apoptosis in a complement-independent manner. Only murine anti-Gal mAbs of the IgM or IgG3 subclass, but not IgG1, were effective at initiating complement-dependent cell lysis. Using a novel rat to mouse xenograft model, we examined the in vivo ability of these mAbs to induce xenograft rejection and characterized the rejection using histology and immunohistochemistry. Infusion of complement-fixing IgG3 mAbs resulted in either hyperacute rejection or acute vascular rejection of the xenograft. Surprisingly, infusion of an equal amount of a high affinity anti-Gal IgG1 mAb, that fixed complement poorly also induced a rapid xenograft rejection, which we have labeled very acute rejection. These studies emphasize the importance of in vivo assays, in addition to in vitro assays, in understanding the role of anti-Gal IgG-mediated tissue injury and xenograft rejection.

[1]  H. Dintzis,et al.  Evaluation of different α-galactosyl glycoconjugates for use in xenotransplantation , 2002 .

[2]  A. Chong,et al.  THE STRUCTURE OF ANTI-GAL IMMUNOGLOBULIN GENES IN NAÏVE AND STIMULATED GAL KNOCKOUT MICE , 2001, Transplantation.

[3]  V. Starnes,et al.  Characteristics of immunoglobulin gene usage of the xenoantibody binding to gal-alpha(1,3)gal target antigens in the gal knockout mouse. , 2001, Transplantation.

[4]  J. Platt,et al.  The role of anti-Galalpha1-3Gal antibodies in acute vascular rejection and accommodation of xenografts. , 2000, Transplantation.

[5]  J. Platt,et al.  THE ROLE OF ANTI-GAL&agr;1-3GAL ANTIBODIES IN ACUTE VASCULAR REJECTION AND ACCOMMODATION OF XENOGRAFTS1 , 2000 .

[6]  A. Chong,et al.  Non‐depleting anti‐CD4, but not anti‐CD8, antibody induces long‐term survival of xenogeneic and allogeneic hearts in α1,3‐galactosyltransferase knockout
(GT‐Ko) mice , 2000, Xenotransplantation.

[7]  A. Chong,et al.  Anti-Galactose-α(1,3)Galactose antibody production in α1,3-Galactosyltransferase gene knockout mice after xeno- and allotransplantation☆ , 2000 .

[8]  J. Platt,et al.  Acute vascular rejection. , 2000, Xenotransplantation.

[9]  M. Goddard,et al.  Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts. , 2000, Transplantation.

[10]  D. Sachs,et al.  High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. , 2000, Transplantation.

[11]  A. Chong,et al.  Anti-galactose-alpha(1,3) galactose antibody production in alpha1,3-galactosyltransferase gene knockout mice after xeno and allo transplantation. , 2000, Transplant immunology.

[12]  D. Cramer,et al.  Natural antibodies and the host immune responses to xenografts , 2000, Xenotransplantation.

[13]  A. Rose,et al.  Venular thrombosis is the key event in the pathogenesis of antibody‐mediated cardiac rejection , 2000, Xenotransplantation.

[14]  J. Banchereau,et al.  Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus. , 2000, Transplantation.

[15]  V. Starnes,et al.  The human antibody response to porcine xenoantigens is encoded by IGHV3-11 and IGHV3-74 IgVH germline progenitors. , 1999, Journal of immunology.

[16]  J. Platt.  Prospects for xenotransplantation , 1999, Pediatric transplantation.

[17]  M. Sandrin,et al.  A murine model of antibody-mediated hyperacute rejection by galactose-alpha(1,3)galactose antibodies in Gal o/o mice. , 1998, Transplantation.

[18]  W. Mckane,et al.  Polymorphism in the human anti-pig natural antibody repertoire: implications for antigen-specific immunoadsorption. , 1998, Transplantation.

[19]  D. Sachs,et al.  Anti-Gal(alpha)1-3Gal antibody response to porcine bone marrow in unmodified baboons and baboons conditioned for tolerance induction. , 1998, Transplantation.

[20]  D. Cramer,et al.  Xenoantibodies to pig endothelium are expressed in germline configuration and share a conserved immunoglobulin VH gene structure with antibodies to common infectious agents. , 1998, Transplantation.

[21]  J. Platt,et al.  Differential recognition by proteins of α-galactosyl residues on endothelial cell surfaces , 1998 .

[22]  A. Dalmasso,et al.  Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: type II activation. , 1998, Transplantation.

[23]  J. Platt,et al.  Humoral responses to pig-to-baboon cardiac transplantation: implications for the pathogenesis and treatment of acute vascular rejection and for accommodation. , 1997, Human immunology.

[24]  M. O'connell,et al.  Characterization of pigs transgenic for human decay-accelerating factor. , 1997, Transplantation.

[25]  J. Platt,et al.  The role of natural anti-Gal alpha 1-3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants. , 1997, Transplant immunology.

[26]  D. Sachs,et al.  Heterogeneity of human anti-pig natural antibodies cross-reactive with the Gal(alpha1,3)Galactose epitope. , 1997, Transplantation.

[27]  D. Cramer,et al.  Human serum reactivity to porcine endothelial cells after antisense-mediated down-regulation of GpIIIa expression. , 1997, Transplantation.

[28]  J. Platt,et al.  Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. , 1997, Transplantation.

[29]  E. Korchagina,et al.  In vivo immunoadsorption of antipig antibodies in baboons using a specific Gal(alpha)1-3Gal column. , 1996, Transplantation.

[30]  C. Ferran,et al.  Delayed xenograft rejection. , 1996, World journal of surgery.

[31]  D. Alexander,et al.  Protein tyrosine phosphatases in T-cell development, apoptosis and signalling. , 1996, Immunology today.

[32]  Thall Ad,et al.  alpha 1,3-Galactosyltransferase-deficient mice produce naturally occurring cytotoxic anti-Gal antibodies. , 1996 .

[33]  A. Robins,et al.  The alpha-1,3-galactosyltransferase knockout mouse. Implications for xenotransplantation. , 1996, Transplantation.

[34]  B. Collins,et al.  THE HUMORAL IMMUNE RESPONSE IN HUMANS FOLLOWING CROSS‐PERFUSION OF PORCINE ORGANS , 1995, Transplantation.

[35]  P. Malý,et al.  Oocyte Galα1,3Gal Epitopes Implicated in Sperm Adhesion to the Zona Pellucida Glycoprotein ZP3 Are Not Required for Fertilization in the Mouse (*) , 1995, The Journal of Biological Chemistry.

[36]  M. Radic,et al.  Human anti-Gal heavy chain genes. Preferential use of VH3 and the presence of somatic mutations. , 1995, Journal of immunology.

[37]  J. Platt,et al.  Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury , 1995, Nature Medicine.

[38]  J. Platt,et al.  Characterization and affinity isolation of xenoreactive human natural antibodies. , 1994, Journal of immunology.

[39]  R. Oriol,et al.  Oligosaccharides and Discordant Xenotransplantation , 1994, Immunological reviews.

[40]  M. Sandrin,et al.  Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[41]  F. Bach,et al.  Human xenoreactive natural antibodies--avidity and targets on porcine endothelial cells. , 1993, Transplantation.

[42]  U. Galili.  Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans. , 1993, Immunology today.

[43]  S. Ben‐Sasson,et al.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.

[44]  D. Cooper,et al.  Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. , 1992, Transplantation proceedings.

[45]  Susumu Tonegawa,et al.  RAG-1-deficient mice have no mature B and T lymphocytes , 1992, Cell.

[46]  W. Baldwin,et al.  THE EFFECT OF SOLUBLE COMPLEMENT RECEPTOR TYPE 1 ON HYPERACUTE XENOGRAFT REJECTION , 1991, Transplantation.

[47]  F. Stevens,et al.  Modification of an ELISA-based procedure for affinity determination: correction necessary for use with bivalent antibody. , 1987, Molecular immunology.

[48]  B. Jasani,et al.  An improved method for the inhibition of endogenous peroxidase non-deleterious to lymphocyte surface markers. Application to immunoperoxidase studies on eosinophil-rich tissue preparations , 1987, The Histochemical Journal.

[49]  A. Chaffotte,et al.  Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. , 1985, Journal of immunological methods.

[50]  M. Pepys,et al.  Activation of mouse complement by different classes of mouse antibody. , 1979, Immunology.

[51]  J. Platt,et al.  Immunochemical Properties of Anti-Galα1–3Gal Antibodies After Sensitization with Xenogeneic Tissues , 2004, Journal of Clinical Immunology.

[52]  野澤 聡志.  Characteristics of immunoglobulin gene usage of the xenoantibody binding to gal-α(1,3)gal target antigens in the Gal knockout mouse , 2002 .

[53]  J. Boezeman,et al.  The dynamic process of apoptosis analyzed by flow cytometry using Annexin-V/propidium iodide and a modified in situ end labeling technique. , 2002, Cytometry.

[54]  Murphy Hs,et al.  A MURINE MODEL OF ANTIBODY-MEDIATED HYPERACUTE REJECTION BY GALACTOSE-a(1,3)GALACTOSE ANTIBODIES IN Gal o/o MICE 1 , 1998 .

[55]  A. Dalmasso,et al.  Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: type I activation. , 1998, Transplantation.

[56]  A. Thall,et al.  alpha 1,3-Galactosyltransferase-deficient mice produce naturally occurring cytotoxic anti-Gal antibodies. , 1996, Transplantation proceedings.